These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay. Kircik LH J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882 [TBL] [Abstract][Full Text] [Related]
4. Halcinonide in the treatment of corticosteroid responsive dermatoses. Leibsohn E; Bagatell FK Br J Dermatol; 1974 Apr; 90(4):435-40. PubMed ID: 4596068 [No Abstract] [Full Text] [Related]
5. Persistent blaschkitis responsive to high potency topical steroids. Liddell LT; Matinpour K; Mir M; McCain C; Diwan AH Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632931 [TBL] [Abstract][Full Text] [Related]
6. Clinical use of topical cortisteroids. Sneddon IB Drugs; 1976; 11(3):193-9. PubMed ID: 776579 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects of topical corticosteroid use. Fisher DA West J Med; 1995 Feb; 162(2):123-6. PubMed ID: 7794369 [TBL] [Abstract][Full Text] [Related]
8. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. Arellano FM; Wentworth CE; Arana A; Fernández C; Paul CF J Invest Dermatol; 2007 Apr; 127(4):808-16. PubMed ID: 17096020 [TBL] [Abstract][Full Text] [Related]
9. The pharmacology of topical steroids. Simon GI Occup Health Saf; 1981 May; 50(5):35-6, 58. PubMed ID: 7231838 [No Abstract] [Full Text] [Related]
10. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. Furue M; Terao H; Moroi Y; Koga T; Kubota Y; Nakayama J; Furukawa F; Tanaka Y; Katayama I; Kinukawa N; Nose Y; Urabe K J Dermatol; 2004 Apr; 31(4):277-83. PubMed ID: 15187322 [TBL] [Abstract][Full Text] [Related]
11. Principles and approaches for optimizing therapy with unique topical vehicles. Rosen J; Landriscina A; Friedman AJ J Drugs Dermatol; 2014 Dec; 13(12):1431-5. PubMed ID: 25607783 [No Abstract] [Full Text] [Related]
12. Topical 'dual-soft' glucocorticoid receptor agonist for dermatology. Dack KN; Johnson PS; Henriksson K; Eirefelt S; Carnerup MA; Stahlhut M; Ollerstam AK Bioorg Med Chem Lett; 2020 Sep; 30(17):127402. PubMed ID: 32738970 [TBL] [Abstract][Full Text] [Related]
13. Contact dermatitis due to topical steroids with conceivable cross reactions between topical steroid preparations. Oh-i T J Dermatol; 1996 Mar; 23(3):200-8. PubMed ID: 8935632 [TBL] [Abstract][Full Text] [Related]
14. [Topical corticosteroids in dermatology--advantages and side effects]. Wojas-Pelc A; Setkowicz M; Bogdaszewska-Czabanowska J Przegl Lek; 2002; 59(3):170-4. PubMed ID: 12184032 [TBL] [Abstract][Full Text] [Related]
16. A practical guide to topical therapy in children. Long CC; Mills CM; Finlay AY Br J Dermatol; 1998 Feb; 138(2):293-6. PubMed ID: 9602877 [TBL] [Abstract][Full Text] [Related]
17. Choosing topical corticosteroids. Ference JD; Last AR Am Fam Physician; 2009 Jan; 79(2):135-40. PubMed ID: 19178066 [TBL] [Abstract][Full Text] [Related]
18. [Editorial: Are we using too potent steroids in the local treatment of skin diseases]. Rajka G Tidsskr Nor Laegeforen; 1975 Nov; 95(32):1867. PubMed ID: 1198570 [No Abstract] [Full Text] [Related]
19. Atopic and seborrheic dermatitis: practical management. David TJ; Devlin J; Ewing CI Pediatrician; 1991; 18(3):211-7. PubMed ID: 1835003 [TBL] [Abstract][Full Text] [Related]